Lynch KR - Search Results

1

International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. Chun J, et al. Among authors: lynch kr. Pharmacol Rev. 2010 Dec;62(4):579-87. doi: 10.1124/pr.110.003111. Pharmacol Rev. 2010. PMID: 21079037 Free PMC article. Review.

2

International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.

Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S, Tigyi G. Chun J, et al. Among authors: lynch kr. Pharmacol Rev. 2002 Jun;54(2):265-9. doi: 10.1124/pr.54.2.265. Pharmacol Rev. 2002. PMID: 12037142 Review.

3

Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.

van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR, Moolenaar WH. van Meeteren LA, et al. Among authors: lynch kr. Cancer Lett. 2008 Aug 8;266(2):203-8. doi: 10.1016/j.canlet.2008.02.052. Epub 2008 Apr 18. Cancer Lett. 2008. PMID: 18378389 Free PMC article.

4

S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor.

Li MH, Sanchez T, Yamase H, Hla T, Oo ML, Pappalardo A, Lynch KR, Lin CY, Ferrer F. Li MH, et al. Among authors: lynch kr. Cancer Lett. 2009 Apr 18;276(2):171-9. doi: 10.1016/j.canlet.2008.11.025. Epub 2009 Jan 7. Cancer Lett. 2009. PMID: 19131156 Free PMC article.

5

Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.

Oo ML, Thangada S, Wu MT, Liu CH, Macdonald TL, Lynch KR, Lin CY, Hla T. Oo ML, et al. Among authors: lynch kr. J Biol Chem. 2007 Mar 23;282(12):9082-9. doi: 10.1074/jbc.M610318200. Epub 2007 Jan 21. J Biol Chem. 2007. PMID: 17237497 Free article.

6

Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.

Li MH, Sanchez T, Pappalardo A, Lynch KR, Hla T, Ferrer F. Li MH, et al. Among authors: lynch kr. Mol Cancer Res. 2008 Oct;6(10):1649-56. doi: 10.1158/1541-7786.MCR-07-2048. Mol Cancer Res. 2008. PMID: 18922980 Free PMC article.

7

Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS.

Sim-Selley LJ, Goforth PB, Mba MU, Macdonald TL, Lynch KR, Milstien S, Spiegel S, Satin LS, Welch SP, Selley DE. Sim-Selley LJ, et al. Among authors: lynch kr. J Neurochem. 2009 Aug;110(4):1191-202. doi: 10.1111/j.1471-4159.2009.06202.x. Epub 2009 May 31. J Neurochem. 2009. PMID: 19493165 Free PMC article.

8

Characterization of a novel sphingosine 1-phosphate receptor, Edg-8.

Im DS, Heise CE, Ancellin N, O'Dowd BF, Shei GJ, Heavens RP, Rigby MR, Hla T, Mandala S, McAllister G, George SR, Lynch KR. Im DS, et al. Among authors: lynch kr. J Biol Chem. 2000 May 12;275(19):14281-6. doi: 10.1074/jbc.275.19.14281. J Biol Chem. 2000. PMID: 10799507 Free article.

9

The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.

Bektas M, Barak LS, Jolly PS, Liu H, Lynch KR, Lacana E, Suhr KB, Milstien S, Spiegel S. Bektas M, et al. Among authors: lynch kr. Biochemistry. 2003 Oct 28;42(42):12181-91. doi: 10.1021/bi035051y. Biochemistry. 2003. PMID: 14567679

10

Lysophospholipid receptor nomenclature.

Lynch KR. Lynch KR. Biochim Biophys Acta. 2002 May 23;1582(1-3):70-1. doi: 10.1016/s1388-1981(02)00138-5. Biochim Biophys Acta. 2002. PMID: 12069811 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page